Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
Healthy Volunteers
NCT06626308

Early Biomarkers in Premanifest Huntington's Disease Gene Carriers: a Pilot Study

Led by University Hospital, Grenoble · Updated on 2025-01-20

20

Participants Needed

1

Research Sites

92 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to investigate if new, early biomarkers of the disease are available in presymptomatic genetic carriers of Huntington\'s diesase compared to healthy subjects. The main questions it aims to answer are: Does functional brain MRI is able to detect early biomarkers of the disease in genetic carriers? Does gait study by a virtual reality device can detect early biomarkers of the disease in genetic carriers? Researchers will compare genetic carriers and healthy subjects to see if new, early biomarkers of the disease can be detected .

CONDITIONS

Official Title

Early Biomarkers in Premanifest Huntington's Disease Gene Carriers: a Pilot Study

Who Can Participate

Age: 18Years - 70Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • For premanifest Huntington's disease gene carriers: confirmed genetic diagnosis with CAG triplets 36 or more in HTT gene
  • Total Motor Score on Unified Huntington Disease Rating Scale of 5 or less
  • Age between 18 and 70 years old
  • For healthy controls: normal neurological examination
  • Age between 18 and 70 years old
Not Eligible

You will not qualify if you...

  • Major active eye diseases
  • Major active psychiatric diseases
  • Cognitive impairment with Montreal Cognitive Assessment (MoCA) score less than 25
  • Gait problems caused by non-neurological conditions
  • Contraindications to brain MRI

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Grenoble University Hospital

Grenoble, France, 38043

Actively Recruiting

Loading map...

Research Team

S

Sara Meoni, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Early Biomarkers in Premanifest Huntington's Disease Gene Carriers: a Pilot Study | DecenTrialz